Prospectus

Aprea Therapeutics, Inc. Filed 2026-03-19 Acc 0001104659-26-032181

Documents 1

2026-04-29 424B3 Prospectus
2026-03-19 EFFECT Notice of Effectiveness
2026-03-19 424B3 Prospectus
2026-03-17 CORRESP Correspondence Between Filers and SEC Staff
2026-03-17 S-3/A Registration Statement
2026-03-16 4 SrVP/CFO/Prin Fin & Acct Ofcr acquired 10,095 shares (grant or award)
2025-12-30 424B3 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading tm269283-1_424b3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…